Arena Pharmaceuticals Inc
CIK 1080709 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Arena Pharmaceuticals Inc.
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Jan 29, 2024 | 4 | 0000078003-24-000012 |
| Mar 21, 2022 | 15-12G | 0001193125-22-079964 |
| Mar 15, 2022 | EFFECT | 9999999995-22-000635 |
| Mar 15, 2022 | EFFECT | 9999999995-22-000634 |
| Mar 15, 2022 | EFFECT | 9999999995-22-000633 |
| Mar 15, 2022 | EFFECT | 9999999995-22-000636 |
| Mar 11, 2022 | POS AM | 0001140361-22-009061 |
| Mar 11, 2022 | S-8 POS | 0001140361-22-009044 |
| Mar 11, 2022 | S-8 POS | 0001140361-22-009052 |
| Mar 11, 2022 | S-8 POS | 0001140361-22-009042 |
| Mar 11, 2022 | 4 | 0001628280-22-005911 |
| Mar 11, 2022 | 4 | 0001628280-22-005887 |
| Mar 11, 2022 | S-8 POS | 0001140361-22-009053 |
| Mar 11, 2022 | 25-NSE | 0001354457-22-000179 |
| Mar 11, 2022 | S-8 POS | 0001140361-22-009050 |
| Mar 11, 2022 | S-8 POS | 0001140361-22-009040 |
| Mar 11, 2022 | 4 | 0001628280-22-005892 |
| Mar 11, 2022 | 4 | 0001628280-22-005884 |
| Mar 11, 2022 | 4 | 0001628280-22-005914 |
| Mar 11, 2022 | 4 | 0001628280-22-005912 |
| Mar 11, 2022 | SC 13G/A | 0000834237-22-009172 |
| Mar 11, 2022 | S-8 POS | 0001140361-22-009043 |
| Mar 11, 2022 | 4 | 0001628280-22-005889 |
| Mar 11, 2022 | 4 | 0001628280-22-005908 |
| Mar 11, 2022 | 4 | 0001628280-22-005885 |